[EN] PYRROLO-BENZO-1,4-DIAZINES USEFUL AS SODIUM CHANNEL BLOCKERS<br/>[FR] PYRROLO-BENZO-1,4-DIAZINES UTILES EN TANT QUE BLOQUEURS DE CANAUX SODIQUES
申请人:SCHERING CORP
公开号:WO2010151595A1
公开(公告)日:2010-12-29
Pyrrolo-benzo-1,4-diazine compounds represented by Formula I or II, or pharmaceutically acceptable salts thereof, are blockers of voltage-gated sodium channels. Pharmaceutical compositions comprise an effective amount of the instant compounds, either alone, or in combination with one or more other therapeutically active compounds, and a pharmaceutically acceptable carrier. Methods of treating conditions associated with, or caused by, voltage-gated sodium channel activity, including, for example, acute pain, chronic pain, visceral pain, inflammatory pain, neuropathic pain, epilepsy or epilepsy conditions, irritable bowel syndrome, depression, anxiety, bipolar disorder, neurodegenerative disorders, psychiatric disorders, myotonia, arrhythmia, movement disorders, neuroendocrine disorders, ataxia, multiple sclerosis, irritable bowel syndrome, incontinence, neuropathy and tinnitus, comprise administering an effective amount of the present compounds, either alone, or in combination with one or more other therapeutically active compounds.
由公式I或II表示的吡咯-苯并-1,4-二嗪化合物或其药学上可接受的盐是电压门控钠通道的阻滞剂。药物组合物包括即时化合物的有效量,可以单独使用,也可以与一个或多个其他治疗活性化合物结合,并且包含药学上可接受的载体。治疗与电压门控钠通道活性相关或由此引起的疾病的方法,包括例如急性疼痛、慢性疼痛、内脏疼痛、炎症性疼痛、神经病性疼痛、癫痫或癫痫症状、肠易激综合征、抑郁症、焦虑症、躁郁症、神经退行性疾病、精神疾病、肌张力过高、心律失常、运动障碍、神经内分泌失调、共济失调、多发性硬化、肠易激综合征、尿失禁、神经病和耳鸣,包括单独或与一个或多个其他治疗活性化合物结合的即时化合物的有效量。